Zodryl DEC 50 is a Oral Suspension in the Human Otc Drug category. It is labeled and distributed by Codadose, Inc.. The primary component is Pseudoephedrine Hydrochloride; Codeine Phosphate; Guaifenesin.
| Product ID | 43378-124_5ace705f-df68-4517-b65a-06c468111906 |
| NDC | 43378-124 |
| Product Type | Human Otc Drug |
| Proprietary Name | Zodryl DEC 50 |
| Generic Name | Codeine Phosphate, Guaifenesin And Pseudoephedrine Hydrochloride |
| Dosage Form | Suspension |
| Route of Administration | ORAL |
| Marketing Start Date | 2009-08-24 |
| Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Labeler Name | CodaDose, Inc. |
| Substance Name | PSEUDOEPHEDRINE HYDROCHLORIDE; CODEINE PHOSPHATE; GUAIFENESIN |
| Active Ingredient Strength | 30 mg/5mL; mg/5mL; mg/5mL |
| DEA Schedule | CV |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Start Date | 2009-08-24 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC monograph final |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2009-08-24 |
| Inactivation Date | 2019-10-21 |
| Ingredient | Strength |
|---|---|
| PSEUDOEPHEDRINE HYDROCHLORIDE | 30 mg/5mL |
| SPL SET ID: | 2abe5326-bf61-410f-84ea-89a39bd954d0 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 43378-124 | Zodryl DEC 50 | codeine phosphate, guaifenesin and pseudoephedrine hydrochloride |
| 43378-120 | Zodryl DEC 25 | codeine phosphate, guaifenesin and pseudoephedrine hydrochloride |
| 43378-121 | Zodryl DEC 30 | codeine phosphate, guaifenesin and pseudoephedrine hydrochloride |
| 43378-123 | Zodryl DEC 40 | codeine phosphate, guaifenesin and pseudoephedrine hydrochloride |
| 43378-125 | Zodryl DEC 60 | codeine phosphate, guaifenesin and pseudoephedrine hydrochloride |
| 43378-126 | Zodryl DEC 80 | codeine phosphate, guaifenesin and pseudoephedrine hydrochloride |